Cargando…
TNFAIP3 mutation may be associated with favorable overall survival for patients with T-cell lymphoma
BACKGROUND: T-cell lymphoma (TCL) is highly aggressive and has a poor prognosis; thus, it is worth exploring biomarkers that may predict clinical outcomes and investigate their potential role in developing targeted therapies. In this study, we characterized the mutation pattern of tumor necrosis fac...
Autores principales: | Chen, Cunte, Chen, Zheng, Huang, Ling, Zhou, Lingling, Zhu, Lihua, Liu, Sichu, Luo, Gengxin, Li, Wenyu, Zeng, Chengwu, Li, Yangqiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444556/ https://www.ncbi.nlm.nih.gov/pubmed/34526012 http://dx.doi.org/10.1186/s12935-021-02191-5 |
Ejemplares similares
-
TNFAIP3
mutation is an independent poor overall survival factor for patients with T‐cell acute lymphoblastic leukemia
por: Chen, Cunte, et al.
Publicado: (2022) -
High expression of TMEM244 is associated with poor overall survival of patients with T-cell lymphoma
por: Chen, Cunte, et al.
Publicado: (2022) -
Tumor mutation burden estimated by a 69-gene-panel is associated with overall survival in patients with diffuse large B-cell lymphoma
por: Chen, Cunte, et al.
Publicado: (2021) -
Low Expression of CD5 and CD6 Is Associated with Poor Overall Survival for Patients with T-Cell Malignancies
por: Sui, Songnan, et al.
Publicado: (2022) -
BCL11B Mutations Are Associated with Higher CD8+ T-Cell Percentage and Favorable Clinical Outcomes in Patients with T-Cell Acute Lymphoblastic Leukemia
por: Chen, Cunte, et al.
Publicado: (2023)